1,2,5,8-tetrahydroxy anthraquinone has been researched along with dichlororibofuranosylbenzimidazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balanda, AO; Bdzhola, VG; Briukhovetska, NV; Golub, AG; Gryshchenko, AA; Kotey, IM; Kukharenko, OP; Ostrynska, OV; Yarmoluk, SM | 1 |
1 other study(ies) available for 1,2,5,8-tetrahydroxy anthraquinone and dichlororibofuranosylbenzimidazole
Article | Year |
---|---|
Design and synthesis of novel protein kinase CK2 inhibitors on the base of 4-aminothieno[2,3-d]pyrimidines.
Topics: Casein Kinase II; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship | 2016 |